Oliver Tracie sold ARWR
January 5, 2024 · Form 4 insider transaction
Oliver Tracie sold 74 shares of Arrowhead Pharmaceuticals, Inc. at $33.89 per share, a transaction worth $2.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
74
Price
$33.89
Total value
$2.5K
InsiderOliver Tracie
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2024
Filing dateJanuary 8, 2024
Shares owned after136,501
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; Partial disposition of RSUs to satisfy tax withholding obligations.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.